Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,773 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sertraline-induced microscopic colitis.
Menon R, Ng C. Menon R, et al. Psychosomatics. 2015 May-Jun;56(3):316-7. doi: 10.1016/j.psym.2014.03.008. Epub 2014 Mar 27. Psychosomatics. 2015. PMID: 25975862 No abstract available.
Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study.
Sarris J, Byrne GJ, Oliver G, Cribb L, Blair-West S, Castle D, Dean OM, Camfield DA, Brakoulias V, Bousman C, Dowling N, Ee C, Murphy J, Menon R, Berk M, Chamoli S, Boschen M, Ng CH. Sarris J, et al. Among authors: menon r. CNS Spectr. 2022 Oct;27(5):588-597. doi: 10.1017/S1092852921000638. Epub 2021 Jun 21. CNS Spectr. 2022. PMID: 34165060 Review.
Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial.
Sarris J, Byrne GJ, Stough C, Bousman C, Mischoulon D, Murphy J, Macdonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng CH. Sarris J, et al. Among authors: menon r. J Affect Disord. 2019 Feb 15;245:1007-1015. doi: 10.1016/j.jad.2018.11.092. Epub 2018 Nov 13. J Affect Disord. 2019. PMID: 30699842 Clinical Trial.
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.
Sarris J, Byrne G, Castle D, Bousman C, Oliver G, Cribb L, Blair-West S, Brakoulias V, Camfield D, Ee C, Chamoli S, Boschen M, Dean OM, Dowling N, Menon R, Murphy J, Metri NJ, Nguyen TP, Wong A, Jordan R, Karamacoska D, Rossell SL, Berk M, Ng CH. Sarris J, et al. Among authors: menon r. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jul 13;117:110550. doi: 10.1016/j.pnpbp.2022.110550. Epub 2022 Mar 15. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 35304155 Clinical Trial.
S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.
Sarris J, Murphy J, Stough C, Mischoulon D, Bousman C, MacDonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng CH, Byrne GJ. Sarris J, et al. Among authors: menon r. Psychopharmacology (Berl). 2020 Jan;237(1):209-218. doi: 10.1007/s00213-019-05358-1. Epub 2019 Nov 11. Psychopharmacology (Berl). 2020. PMID: 31712971 Clinical Trial.
1,773 results